| 228 Treffer |
| ART-NR | PRODUKT | HERSTELLER | MENGE | PREIS |
| Cay34350-25 |
CAS: 105500-09-2 Bioactive lipid assays  8(R)-HETE is biosynthesized by lipoxygenation of arachidonic acid in marine invertebrates such as gorgonian corals and starfish. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
 |
| Cay34360-25 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM and also activates PPAR.alpha. selectively at concentrations as low as 0.3 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay34505-25 |
CAS: 73347-43-0 Bioactive lipid assays 11(R)-HETE is biosynthesized by the 11(R)-LOs of the sea urchin, S. purpuratus, and the fresh water hydra, H. vulgaris. 11(R)-HETE is also produced when aspirin-treated recombinant COX-2 is incubated with arachidonic acid. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay34510-0.025 |
CAS: 54886-50-9 Bioactive lipid studies The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay34560-25 |
CAS: 82337-46-0 Bioactive lipid assays In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay90030-25 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10004384-100 |
CAS: 183509-23-1 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10004384-25 |
CAS: 183509-23-1 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10004384-50 |
CAS: 183509-23-1 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10004384-500 |
CAS: 183509-23-1 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10004385-100 |
CAS: 183509-22-0 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10004385-25 |
CAS: 183509-22-0 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10004385-50 |
CAS: 183509-22-0 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10004385-500 |
CAS: 183509-22-0 Bioactive lipid assays 16-HETE is a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation that demonstrates stereospecific biological activity. 16(S)-HETE inhibits proximal tubule ATPase activity by as much as 60% at a concentration ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10006998-100 |
Bioactive lipid assays 14,15-DiHETE is one of the major metabolites produced when EPA is incubated with rat liver microsomes and a rat colitis homogenate. 14,15-DiHETE is excreted in significant quantities by humans ingesting fish oil supplements. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
288 €
|
| Cay10006998-25 |
Bioactive lipid assays 14,15-DiHETE is one of the major metabolites produced when EPA is incubated with rat liver microsomes and a rat colitis homogenate. 14,15-DiHETE is excreted in significant quantities by humans ingesting fish oil supplements. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
80 €
|
| Cay10006998-250 |
Bioactive lipid assays 14,15-DiHETE is one of the major metabolites produced when EPA is incubated with rat liver microsomes and a rat colitis homogenate. 14,15-DiHETE is excreted in significant quantities by humans ingesting fish oil supplements. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
640 €
|
| Cay10006998-50 |
Bioactive lipid assays 14,15-DiHETE is one of the major metabolites produced when EPA is incubated with rat liver microsomes and a rat colitis homogenate. 14,15-DiHETE is excreted in significant quantities by humans ingesting fish oil supplements. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
152 €
|
| Cay10006999-100 |
Bioactive lipid assays Eicosapentaenoic acid (EPA) is an .omega.-3 fatty acid abundantly available in marine organisms. 17,18-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
288 €
|
| Cay10006999-25 |
Bioactive lipid assays Eicosapentaenoic acid (EPA) is an .omega.-3 fatty acid abundantly available in marine organisms. 17,18-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
80 €
|
| Cay10006999-250 |
Bioactive lipid assays Eicosapentaenoic acid (EPA) is an .omega.-3 fatty acid abundantly available in marine organisms. 17,18-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
640 €
|
| Cay10006999-50 |
Bioactive lipid assays Eicosapentaenoic acid (EPA) is an .omega.-3 fatty acid abundantly available in marine organisms. 17,18-DiHETE is one of the major metabolites produced when EPA is incubated with various rat tissue homogenates or cynomolgus monkey seminal vesicles. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
152 €
|
| Cay10007207-100 |
CAS: 121842-79-3 Bioactive lipid assays tetranor-12(S)-HETE is the major .beta.-oxidation product resulting from the peroxisome metabolism of 12(S)-HETE in numerous tissues, and Lewis lung carcinoma cells. No biological function has yet been determined for tetranor-12(S)-HETE. MW: 266 D Formula: C16H26O3 Purity: >98% |
Cayman |
100 µg |
426 €
|
| Cay10007207-25 |
CAS: 121842-79-3 Bioactive lipid assays tetranor-12(S)-HETE is the major .beta.-oxidation product resulting from the peroxisome metabolism of 12(S)-HETE in numerous tissues, and Lewis lung carcinoma cells. No biological function has yet been determined for tetranor-12(S)-HETE. MW: 266 D Formula: C16H26O3 Purity: >98% |
Cayman |
25 µg |
118 €
|
| Cay10007207-50 |
CAS: 121842-79-3 Bioactive lipid assays tetranor-12(S)-HETE is the major .beta.-oxidation product resulting from the peroxisome metabolism of 12(S)-HETE in numerous tissues, and Lewis lung carcinoma cells. No biological function has yet been determined for tetranor-12(S)-HETE. MW: 266 D Formula: C16H26O3 Purity: >98% |
Cayman |
50 µg |
225 €
|
| Cay10007243-100 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE is produced by the action of 5-LO on arachidonic acid to give 5(S)-HpETE, followed by reduction of the hydroperoxide. 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
380 €
|
| Cay10007243-25 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE is produced by the action of 5-LO on arachidonic acid to give 5(S)-HpETE, followed by reduction of the hydroperoxide. 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
106 €
|
| Cay10007243-250 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE is produced by the action of 5-LO on arachidonic acid to give 5(S)-HpETE, followed by reduction of the hydroperoxide. 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
844 €
|
| Cay10007243-50 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE is produced by the action of 5-LO on arachidonic acid to give 5(S)-HpETE, followed by reduction of the hydroperoxide. 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
199 €
|
| Cay10007245-100 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM. 8(S)-HETE also activates peroxisome proliferator-activated receptor a selectively at concentrations as low ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
485 €
|
| Cay10007245-25 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM. 8(S)-HETE also activates peroxisome proliferator-activated receptor a selectively at concentrations as low ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
135 €
|
| Cay10007245-50 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM. 8(S)-HETE also activates peroxisome proliferator-activated receptor a selectively at concentrations as low ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
255 €
|
| Cay10007246-100 |
CAS: 54886-50-9 MS standard The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
485 €
|
| Cay10007246-25 |
CAS: 54886-50-9 MS standard The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
135 €
|
| Cay10007246-50 |
CAS: 54886-50-9 MS standard The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
255 €
|
| Cay10007247-100 |
CAS: 82337-46-0 Bioactive lipid assays Biosynthesis of 12(R)-HETE in invertebrates is via lipoxygenation of arachidonic acid. In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
485 €
|
| Cay10007247-25 |
CAS: 82337-46-0 Bioactive lipid assays Biosynthesis of 12(R)-HETE in invertebrates is via lipoxygenation of arachidonic acid. In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
135 €
|
| Cay10007247-50 |
CAS: 82337-46-0 Bioactive lipid assays Biosynthesis of 12(R)-HETE in invertebrates is via lipoxygenation of arachidonic acid. In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
255 €
|
| Cay10007248-100 |
CAS: 54397-83-0 MS standard 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
485 €
|
| Cay10007248-25 |
CAS: 54397-83-0 MS standard 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
135 €
|
| Cay10007248-50 |
CAS: 54397-83-0 MS standard 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
255 €
|
| Cay10007251-100 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes.{118} 15(S)-HETE is present in µg/ml concentrations in the nasal secret ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
151 €
|
| Cay10007251-25 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes.{118} 15(S)-HETE is present in µg/ml concentrations in the nasal secret ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
42 €
|
| Cay10007251-50 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes.{118} 15(S)-HETE is present in µg/ml concentrations in the nasal secret ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
79 €
|
| Cay10007251-500 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes.{118} 15(S)-HETE is present in µg/ml concentrations in the nasal secret ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
668 €
|
| Cay10007252-100 |
CAS: 82948-88-7 MS standard 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >99% |
Cayman |
100 µg |
392 €
|
| Cay10007252-25 |
CAS: 82948-88-7 MS standard 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >99% |
Cayman |
25 µg |
109 €
|
| Cay10007252-250 |
CAS: 82948-88-7 MS standard 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >99% |
Cayman |
250 µg |
872 €
|
| Cay10007252-50 |
CAS: 82948-88-7 MS standard 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >99% |
Cayman |
50 µg |
208 €
|
| Cay10007253-100 |
CAS: 82948-87-6 MS standard 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
655 €
|
| Cay10007253-25 |
CAS: 82948-87-6 MS standard 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
182 €
|
| Cay10007253-250 |
CAS: 82948-87-6 MS standard 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
1457 €
|
| Cay10007253-50 |
CAS: 82948-87-6 MS standard 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
346 €
|
| Cay10007255-100 |
CAS: 82200-87-1 MS standard 5(S),15(S)-DiHETE is synthesized by 15-LO from 5(S)-HETE. It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
318 €
|
| Cay10007255-25 |
CAS: 82200-87-1 MS standard 5(S),15(S)-DiHETE is synthesized by 15-LO from 5(S)-HETE. It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
88 €
|
| Cay10007255-250 |
CAS: 82200-87-1 MS standard 5(S),15(S)-DiHETE is synthesized by 15-LO from 5(S)-HETE. It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
699 €
|
| Cay10007255-50 |
CAS: 82200-87-1 MS standard 5(S),15(S)-DiHETE is synthesized by 15-LO from 5(S)-HETE. It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
167 €
|
| Cay10007269-100 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
551 €
|
| Cay10007269-25 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
153 €
|
| Cay10007269-50 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
291 €
|
| Cay10007269-500 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2450 €
|
| Cay10007276-100 |
Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
100 µg |
577 €
|
| Cay10007276-25 |
Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
25 µg |
160 €
|
| Cay10007276-50 |
Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
50 µg |
299 €
|
| Cay10007276-500 |
Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
500 µg |
2561 €
|
| Cay10007766-100 |
CAS: 115461-40-0 Bioactive lipid assays 19-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, re ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10007766-25 |
CAS: 115461-40-0 Bioactive lipid assays 19-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, re ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10007766-50 |
CAS: 115461-40-0 Bioactive lipid assays 19-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, re ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10007766-500 |
CAS: 115461-40-0 Bioactive lipid assays 19-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, re ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10007767-100 |
CAS: 115461-39-7 Bioactive lipid assays 9-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, res ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10007767-25 |
CAS: 115461-39-7 Bioactive lipid assays 9-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, res ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10007767-50 |
CAS: 115461-39-7 Bioactive lipid assays 9-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, res ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10007767-500 |
CAS: 115461-39-7 Bioactive lipid assays 9-HETE is one of the major cytochrome P450 (CYP450) metabolites of arachidonic acid that is released from the kidney in response to angiotensin II. When formed by the CYP2E1 isoform, 19-HETE is composed of 70% and 30% of the (S) and (R) stereoisomers, res ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10008602-0.025 |
CYP450 metabolism studies Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the ... mehr MW: 363 D Formula: C22H37NO3 Purity: >98% |
Cayman |
25 µg |
212 €
|
| Cay10008602-0.05 |
CYP450 metabolism studies Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the ... mehr MW: 363 D Formula: C22H37NO3 Purity: >98% |
Cayman |
50 µg |
399 €
|
| Cay10008602-0.1 |
CYP450 metabolism studies Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. Fatty acid amide hydrolase (FAAH) is the enzyme responsible for the ... mehr MW: 363 D Formula: C22H37NO3 Purity: >98% |
Cayman |
100 µg |
764 €
|
| Cay10009628-0.025 |
Bioactive lipid studies 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE that is formed by the enzymatic isomerization of 5(S),6(R)-DiHETE by a membrane bound factor. 5(S),6(R)-11-trans DiHETE has been found in rat kidney homogenates and is potentially ... mehr MW: 336 D Formula: C20H32O4 Purity: >95% |
Cayman |
25 µg |
99 €
|
| Cay10009628-0.05 |
Bioactive lipid studies 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE that is formed by the enzymatic isomerization of 5(S),6(R)-DiHETE by a membrane bound factor. 5(S),6(R)-11-trans DiHETE has been found in rat kidney homogenates and is potentially ... mehr MW: 336 D Formula: C20H32O4 Purity: >95% |
Cayman |
50 µg |
189 €
|
| Cay10009628-0.1 |
Bioactive lipid studies 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE that is formed by the enzymatic isomerization of 5(S),6(R)-DiHETE by a membrane bound factor. 5(S),6(R)-11-trans DiHETE has been found in rat kidney homogenates and is potentially ... mehr MW: 336 D Formula: C20H32O4 Purity: >95% |
Cayman |
100 µg |
360 €
|
| Cay10009628-0.25 |
Bioactive lipid studies 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE that is formed by the enzymatic isomerization of 5(S),6(R)-DiHETE by a membrane bound factor. 5(S),6(R)-11-trans DiHETE has been found in rat kidney homogenates and is potentially ... mehr MW: 336 D Formula: C20H32O4 Purity: >95% |
Cayman |
500 µg |
1596 €
|
| Cay10010635-100 |
CAS: 128914-46-5 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)16-HETE is the racemic version of a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10010635-25 |
CAS: 128914-46-5 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)16-HETE is the racemic version of a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10010635-50 |
CAS: 128914-46-5 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)16-HETE is the racemic version of a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10010635-500 |
CAS: 128914-46-5 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)16-HETE is the racemic version of a minor CYP450 metabolite of arachidonic acid released by the kidney upon angiotensin II stimulation. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10010636-100 |
CAS: 128914-47-6 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)17-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transpor ... mehr MW: 320 D Formula: CC20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10010636-25 |
CAS: 128914-47-6 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)17-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transpor ... mehr MW: 320 D Formula: CC20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10010636-50 |
CAS: 128914-47-6 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)17-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transpor ... mehr MW: 320 D Formula: CC20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10010636-500 |
CAS: 128914-47-6 Bioactive lipid assays Electrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites. (±)17-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transpor ... mehr MW: 320 D Formula: CC20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10010637-100 |
CAS: 183509-24-2 Bioactive lipid assays 17(R)-HETE is an inactive isomer of 17-HETE, whereas the (S) enantiomer can inhibit proximal tubule ATPase activity at a concentration of 2 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10010637-25 |
CAS: 183509-24-2 Bioactive lipid assays 17(R)-HETE is an inactive isomer of 17-HETE, whereas the (S) enantiomer can inhibit proximal tubule ATPase activity at a concentration of 2 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10010637-50 |
CAS: 183509-24-2 Bioactive lipid assays 17(R)-HETE is an inactive isomer of 17-HETE, whereas the (S) enantiomer can inhibit proximal tubule ATPase activity at a concentration of 2 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10010637-500 |
CAS: 183509-24-2 Bioactive lipid assays 17(R)-HETE is an inactive isomer of 17-HETE, whereas the (S) enantiomer can inhibit proximal tubule ATPase activity at a concentration of 2 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
| Cay10010638-100 |
CAS: 133268-58-3 Bioactive lipid assays (±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid. When formed by the CYP2E1 isoform, 18-HETE is comprised 100% of the (R) isomer. MW: 320 D Formula: C20H32O3 Purity: >97% |
Cayman |
100 µg |
499 €
|
| Cay10010638-25 |
CAS: 133268-58-3 Bioactive lipid assays (±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid. When formed by the CYP2E1 isoform, 18-HETE is comprised 100% of the (R) isomer. MW: 320 D Formula: C20H32O3 Purity: >97% |
Cayman |
25 µg |
139 €
|
| Cay10010638-50 |
CAS: 133268-58-3 Bioactive lipid assays (±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid. When formed by the CYP2E1 isoform, 18-HETE is comprised 100% of the (R) isomer. MW: 320 D Formula: C20H32O3 Purity: >97% |
Cayman |
50 µg |
264 €
|
| Cay10010638-500 |
CAS: 133268-58-3 Bioactive lipid assays (±)18-HETE is the racemic version of a cytochrome P450 (CYP450) metabolite of arachidonic acid. When formed by the CYP2E1 isoform, 18-HETE is comprised 100% of the (R) isomer. MW: 320 D Formula: C20H32O3 Purity: >97% |
Cayman |
500 µg |
2227 €
|
| Cay10011305-100 |
CAS: 183509-25-3 Bioactive lipid assays lectrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.17-HETE is a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transport in the kidney. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10011305-25 |
CAS: 183509-25-3 Bioactive lipid assays lectrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.17-HETE is a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transport in the kidney. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10011305-50 |
CAS: 183509-25-3 Bioactive lipid assays lectrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.17-HETE is a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transport in the kidney. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10011305-500 |
CAS: 183509-25-3 Bioactive lipid assays lectrolyte and fluid transport in the kidney are regulated in part by arachidonic acid and its metabolites.17-HETE is a cytochrome P450 (CYP450) metabolite of arachidonic acid that has stereospecific effects on sodium transport in the kidney. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
1911 €
|
| Cay10169-100 |
CAS: 161744-53-2 Bioactive lipid assays Lipoxygenases, especially rabbit reticulocyte and soybean 15-lipoxygenases, actively convert endocannabinoids to their 15(S)-hydroperoxy and hydroxy metabolites. 15(S)-HETE ethanolamide is less potent than AEA at the CB1 receptor (Ki of 600 versus 90 nM). ... mehr MW: 363 D Formula: C22H37NO3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay10169-25 |
CAS: 161744-53-2 Bioactive lipid assays Lipoxygenases, especially rabbit reticulocyte and soybean 15-lipoxygenases, actively convert endocannabinoids to their 15(S)-hydroperoxy and hydroxy metabolites. 15(S)-HETE ethanolamide is less potent than AEA at the CB1 receptor (Ki of 600 versus 90 nM). ... mehr MW: 363 D Formula: C22H37NO3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay10169-50 |
CAS: 161744-53-2 Bioactive lipid assays Lipoxygenases, especially rabbit reticulocyte and soybean 15-lipoxygenases, actively convert endocannabinoids to their 15(S)-hydroperoxy and hydroxy metabolites. 15(S)-HETE ethanolamide is less potent than AEA at the CB1 receptor (Ki of 600 versus 90 nM). ... mehr MW: 363 D Formula: C22H37NO3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay10467-100 |
CAS: 845673-97-4 Metabolic studies Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that is abundant in marine organisms and fish oils. EPA is metabolized, in part, through cytochrome P450-catalyzed epoxidation followed by conversion to the vicinal diols by epoxide hydr ... mehr MW: 336 D Formula: C20H32O4 Purity: >97% |
Cayman |
100 µg |
288 €
|
| Cay10467-25 |
CAS: 845673-97-4 Metabolic studies Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that is abundant in marine organisms and fish oils. EPA is metabolized, in part, through cytochrome P450-catalyzed epoxidation followed by conversion to the vicinal diols by epoxide hydr ... mehr MW: 336 D Formula: C20H32O4 Purity: >97% |
Cayman |
25 µg |
80 €
|
| Cay10467-250 |
CAS: 845673-97-4 Metabolic studies Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that is abundant in marine organisms and fish oils. EPA is metabolized, in part, through cytochrome P450-catalyzed epoxidation followed by conversion to the vicinal diols by epoxide hydr ... mehr MW: 336 D Formula: C20H32O4 Purity: >97% |
Cayman |
250 µg |
640 €
|
| Cay10467-50 |
CAS: 845673-97-4 Metabolic studies Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that is abundant in marine organisms and fish oils. EPA is metabolized, in part, through cytochrome P450-catalyzed epoxidation followed by conversion to the vicinal diols by epoxide hydr ... mehr MW: 336 D Formula: C20H32O4 Purity: >97% |
Cayman |
50 µg |
152 €
|
| Cay334230-100 |
CAS: 330796-62-8 Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
100 µg |
522 €
|
| Cay334230-25 |
CAS: 330796-62-8 Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
25 µg |
145 €
|
| Cay334230-50 |
CAS: 330796-62-8 Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
50 µg |
276 €
|
| Cay334230-500 |
CAS: 330796-62-8 Standard 5(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 5(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
500 µg |
2320 €
|
| Cay334570-100 |
CAS: 84807-90-9 Standard 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
100 µg |
499 €
|
| Cay334570-25 |
CAS: 84807-90-9 Standard 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
25 µg |
139 €
|
Cay334570-50 |
CAS: 84807-90-9 Standard 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
50 µg |
anfragen
|
| Cay334720-100 |
CAS: 84807-87-4 Standard 15(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 15(S)-HETE by GC- or LC-MS. MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
100 µg |
422 €
|
| Cay334720-25 |
CAS: 84807-87-4 Standard 15(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 15(S)-HETE by GC- or LC-MS. MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
25 µg |
117 €
|
| Cay334720-50 |
CAS: 84807-87-4 Standard 15(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14, and 15 positions. It is intended for use as an internal standard for the quantification of 15(S)-HETE by GC- or LC-MS. MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
50 µg |
223 €
|
| Cay34001-1 |
(S)-HETE HPLC Mixture Bioactive lipid assays This mixture contains each of the (S)-monohydroxy lipoxygenase products of arachidonic acid. Contents: 5(S)-HETE, 8(S)-HETE, 11(S)-HETE, 12(S)-HETE, and 15(S)-HETE (5 µg each). Purity: >98% for each compound |
Cayman |
1 each |
195 €
|
| Cay34002-1 |
(±)-HETE HPLC Mixture Standard The (±)-HETE HPLC mixture contains a combination of (±)-HETEs supplied in ethanol. This HPLC mixture contains 5 µg of the following HETEs: (±)5-HETE, (±)8-HETE, (±)11-HETE, (±)12-HETE, and (±)15-HETE. Purity: >98% |
Cayman |
1 each |
137 €
|
| Cay34210-0.025 |
CAS: 73307-52-5 Bioactive lipid studies (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. It contains equal amounts of 5(S)-HETE and 5(R)-HETE. (±)5-HETE induces the aggregation of isolated neutrophils with an IC50 value of 200 nM ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
36 €
|
| Cay34210-0.05 |
CAS: 73307-52-5 Bioactive lipid studies (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. It contains equal amounts of 5(S)-HETE and 5(R)-HETE. (±)5-HETE induces the aggregation of isolated neutrophils with an IC50 value of 200 nM ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
68 €
|
| Cay34210-0.1 |
CAS: 73307-52-5 Bioactive lipid studies (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. It contains equal amounts of 5(S)-HETE and 5(R)-HETE. (±)5-HETE induces the aggregation of isolated neutrophils with an IC50 value of 200 nM ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
130 €
|
| Cay34210-0.5 |
CAS: 73307-52-5 Bioactive lipid studies (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. It contains equal amounts of 5(S)-HETE and 5(R)-HETE. (±)5-HETE induces the aggregation of isolated neutrophils with an IC50 value of 200 nM ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
575 €
|
| Cay34215-0.05 |
CAS: 73279-37-5 5-LO inhibitor (±)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (±)5-HETE. It is an inhibitor of 5-lipoxygenase from rat basophilic leukemia cells with an IC50 of 27 µM. MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
50 µg |
78 €
|
| Cay34215-0.1 |
CAS: 73279-37-5 5-LO inhibitor (±)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (±)5-HETE. It is an inhibitor of 5-lipoxygenase from rat basophilic leukemia cells with an IC50 of 27 µM. MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
100 µg |
146 €
|
| Cay34215-0.5 |
CAS: 73279-37-5 5-LO inhibitor (±)5-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of (±)5-HETE. It is an inhibitor of 5-lipoxygenase from rat basophilic leukemia cells with an IC50 of 27 µM. MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
500 µg |
650 €
|
| Cay34220-0.025 |
CAS: 73279-38-6 Standard (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (±)5-HETE has no distinguishing biological activity and is supplied as a standard. Oxidatively degraded polyunsaturated ... mehr MW: 334 D Formula: C21H34O3 Purity: >98% |
Cayman |
25 µg |
29 €
|
| Cay34220-0.05 |
CAS: 73279-38-6 Standard (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (±)5-HETE has no distinguishing biological activity and is supplied as a standard. Oxidatively degraded polyunsaturated ... mehr MW: 334 D Formula: C21H34O3 Purity: >98% |
Cayman |
50 µg |
56 €
|
| Cay34220-0.1 |
CAS: 73279-38-6 Standard (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (±)5-HETE has no distinguishing biological activity and is supplied as a standard. Oxidatively degraded polyunsaturated ... mehr MW: 334 D Formula: C21H34O3 Purity: >98% |
Cayman |
100 µg |
104 €
|
| Cay34220-0.25 |
CAS: 73279-38-6 Standard (±)5-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The methyl ester of (±)5-HETE has no distinguishing biological activity and is supplied as a standard. Oxidatively degraded polyunsaturated ... mehr MW: 334 D Formula: C21H34O3 Purity: >98% |
Cayman |
250 µg |
232 €
|
| Cay34225-100 |
CAS: 61641-47-2 Bioactive lipid assays 5(R)-HETE is a rare lipoxygenase product of arachidonic acid. 5(R)-HETE is more potent than the (S)-enantiomer as a chemotactic agent for human neutrophils. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
299 €
|
| Cay34225-25 |
CAS: 61641-47-2 Bioactive lipid assays 5(R)-HETE is a rare lipoxygenase product of arachidonic acid. 5(R)-HETE is more potent than the (S)-enantiomer as a chemotactic agent for human neutrophils. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
84 €
|
| Cay34225-250 |
CAS: 61641-47-2 Bioactive lipid assays 5(R)-HETE is a rare lipoxygenase product of arachidonic acid. 5(R)-HETE is more potent than the (S)-enantiomer as a chemotactic agent for human neutrophils. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
632 €
|
| Cay34225-50 |
CAS: 61641-47-2 Bioactive lipid assays 5(R)-HETE is a rare lipoxygenase product of arachidonic acid. 5(R)-HETE is more potent than the (S)-enantiomer as a chemotactic agent for human neutrophils. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
158 €
|
| Cay34230-100 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent eosinophil chemoattractant than leukotriene B4. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
347 €
|
| Cay34230-25 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent eosinophil chemoattractant than leukotriene B4. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
103 €
|
| Cay34230-250 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent eosinophil chemoattractant than leukotriene B4. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
777 €
|
| Cay34230-50 |
CAS: 70608-72-9 Bioactive lipid assays 5(S)-HETE has proliferative and chemotactic effects on granulocytes. When further metabolized to 5-oxoETE, it is a more potent eosinophil chemoattractant than leukotriene B4. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
186 €
|
| Cay34240-0.025 |
CAS: 127708-42-3 Bioactive lipid studies 5(S)-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of 5(S)-HETE. The ability of (±)5-HETE lactone to inhibit rat basophilic leukemia cell 5-lipoxygenase (IC50 = 27 µM) may be entire ... mehr MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
25 µg |
108 €
|
| Cay34240-0.05 |
CAS: 127708-42-3 Bioactive lipid studies 5(S)-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of 5(S)-HETE. The ability of (±)5-HETE lactone to inhibit rat basophilic leukemia cell 5-lipoxygenase (IC50 = 27 µM) may be entire ... mehr MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
50 µg |
205 €
|
| Cay34240-0.1 |
CAS: 127708-42-3 Bioactive lipid studies 5(S)-HETE lactone is a cyclic ester formed by acid-catalyzed nucleophilic addition of the C-5 hydroxyl to the C-1 carboxyl of 5(S)-HETE. The ability of (±)5-HETE lactone to inhibit rat basophilic leukemia cell 5-lipoxygenase (IC50 = 27 µM) may be entire ... mehr MW: 302 D Formula: C20H30O2 Purity: >98% |
Cayman |
100 µg |
389 €
|
| Cay34340-0.025 |
CAS: 79495-84-4 Bioactive lipid studies (±)8-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)8-HETE is likely to resemble that of its constituent enantiomers (Catalog Nos. Cay34350 and Cay34360). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
56 €
|
| Cay34340-0.05 |
CAS: 79495-84-4 Bioactive lipid studies (±)8-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)8-HETE is likely to resemble that of its constituent enantiomers (Catalog Nos. Cay34350 and Cay34360). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
106 €
|
| Cay34340-0.1 |
CAS: 79495-84-4 Bioactive lipid studies (±)8-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)8-HETE is likely to resemble that of its constituent enantiomers (Catalog Nos. Cay34350 and Cay34360). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
199 €
|
| Cay34340-0.25 |
CAS: 79495-84-4 Bioactive lipid studies (±)8-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)8-HETE is likely to resemble that of its constituent enantiomers (Catalog Nos. Cay34350 and Cay34360). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
445 €
|
| Cay34350-100 |
CAS: 105500-09-2 Bioactive lipid assays 8(R)-HETE is biosynthesized by lipoxygenation of arachidonic acid in marine invertebrates such as gorgonian corals and starfish. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay34350-250 |
CAS: 105500-09-2 Bioactive lipid assays 8(R)-HETE is biosynthesized by lipoxygenation of arachidonic acid in marine invertebrates such as gorgonian corals and starfish. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
1169 €
|
| Cay34350-50 |
CAS: 105500-09-2 Bioactive lipid assays 8(R)-HETE is biosynthesized by lipoxygenation of arachidonic acid in marine invertebrates such as gorgonian corals and starfish. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay34360-100 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM and also activates PPAR.alpha. selectively at concentrations as low as 0.3 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
441 €
|
| Cay34360-250 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM and also activates PPAR.alpha. selectively at concentrations as low as 0.3 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
974 €
|
| Cay34360-50 |
CAS: 98462-03-4 Bioactive lipid assays 8(S)-HETE is a major lipoxygenase product in PMA-treated mouse epidermis. It activates mouse keratinocyte protein kinase C with an IC50 of 100 µM and also activates PPAR.alpha. selectively at concentrations as low as 0.3 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
232 €
|
| Cay34400-100 |
CAS: 79495-85-5 Bioactive lipid assays MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
347 €
|
| Cay34400-25 |
CAS: 79495-85-5 Bioactive lipid assays MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
96 €
|
| Cay34400-250 |
CAS: 79495-85-5 Bioactive lipid assays MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
770 €
|
| Cay34400-50 |
CAS: 79495-85-5 Bioactive lipid assays MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
184 €
|
| Cay34405-0.025 |
CAS: 107656-14-4 Bioactive lipid studies 9(R)-HETE is an enantiomer which makes up 50% of (±)9-HETE. At a concentration of 300 nM, 9(R)-HETE activates RXRgamma-dependent transcription 1.5 fold relative to a control. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay34405-0.05 |
CAS: 107656-14-4 Bioactive lipid studies 9(R)-HETE is an enantiomer which makes up 50% of (±)9-HETE. At a concentration of 300 nM, 9(R)-HETE activates RXRgamma-dependent transcription 1.5 fold relative to a control. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay34405-0.1 |
CAS: 107656-14-4 Bioactive lipid studies 9(R)-HETE is an enantiomer which makes up 50% of (±)9-HETE. At a concentration of 300 nM, 9(R)-HETE activates RXRgamma-dependent transcription 1.5 fold relative to a control. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay34405-0.25 |
CAS: 107656-14-4 Bioactive lipid studies 9(R)-HETE is an enantiomer which makes up 50% of (±)9-HETE. At a concentration of 300 nM, 9(R)-HETE activates RXRgamma-dependent transcription 1.5 fold relative to a control. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
1169 €
|
| Cay34410-0.025 |
CAS: 107656-13-3 Bioactive lipid studies 9(S)-HETE is an enantiomer which makes up 50% of (±)9-HETE. There are no reports of 9(S)-HETE occurring as an enzymatic lipoxygenation product. Whereas 12(S)-HETE promotes adhesion of several cell lines to endothelial cell monolayes, 9(S)-HETE and other ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay34410-0.05 |
CAS: 107656-13-3 Bioactive lipid studies 9(S)-HETE is an enantiomer which makes up 50% of (±)9-HETE. There are no reports of 9(S)-HETE occurring as an enzymatic lipoxygenation product. Whereas 12(S)-HETE promotes adhesion of several cell lines to endothelial cell monolayes, 9(S)-HETE and other ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay34410-0.1 |
CAS: 107656-13-3 Bioactive lipid studies 9(S)-HETE is an enantiomer which makes up 50% of (±)9-HETE. There are no reports of 9(S)-HETE occurring as an enzymatic lipoxygenation product. Whereas 12(S)-HETE promotes adhesion of several cell lines to endothelial cell monolayes, 9(S)-HETE and other ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay34410-0.25 |
CAS: 107656-13-3 Bioactive lipid studies 9(S)-HETE is an enantiomer which makes up 50% of (±)9-HETE. There are no reports of 9(S)-HETE occurring as an enzymatic lipoxygenation product. Whereas 12(S)-HETE promotes adhesion of several cell lines to endothelial cell monolayes, 9(S)-HETE and other ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
974 €
|
| Cay34500-0.025 |
CAS: 73804-65-6 Bioactive lipid studies (±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC. The racemic HETEs have been quan ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
56 €
|
| Cay34500-0.05 |
CAS: 73804-65-6 Bioactive lipid studies (±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC. The racemic HETEs have been quan ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
106 €
|
| Cay34500-0.1 |
CAS: 73804-65-6 Bioactive lipid studies (±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC. The racemic HETEs have been quan ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
199 €
|
| Cay34500-0.25 |
CAS: 73804-65-6 Bioactive lipid studies (±)11-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The individual R and S isomers of racemic HETEs have been separated and identified using chiral phase HPLC. The racemic HETEs have been quan ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
445 €
|
| Cay34505-100 |
CAS: 73347-43-0 Bioactive lipid assays 11(R)-HETE is biosynthesized by the 11(R)-LOs of the sea urchin, S. purpuratus, and the fresh water hydra, H. vulgaris. 11(R)-HETE is also produced when aspirin-treated recombinant COX-2 is incubated with arachidonic acid. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay34505-250 |
CAS: 73347-43-0 Bioactive lipid assays 11(R)-HETE is biosynthesized by the 11(R)-LOs of the sea urchin, S. purpuratus, and the fresh water hydra, H. vulgaris. 11(R)-HETE is also produced when aspirin-treated recombinant COX-2 is incubated with arachidonic acid. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
1169 €
|
| Cay34505-50 |
CAS: 73347-43-0 Bioactive lipid assays 11(R)-HETE is biosynthesized by the 11(R)-LOs of the sea urchin, S. purpuratus, and the fresh water hydra, H. vulgaris. 11(R)-HETE is also produced when aspirin-treated recombinant COX-2 is incubated with arachidonic acid. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay34510-0.05 |
CAS: 54886-50-9 Bioactive lipid studies The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay34510-0.1 |
CAS: 54886-50-9 Bioactive lipid studies The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay34510-0.25 |
CAS: 54886-50-9 Bioactive lipid studies The synthesis of 11-HETE by rat PMNL has been reported, but the stereochemistry of the 11-HETE produced is not defined. There are no definitive reports of a mammalian 11(S)-LO. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
974 €
|
| Cay34550-0.025 |
CAS: 71030-37-0 Bioactive lipid studies (±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)12-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34560 and Cay34570). It aggregates ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
67 €
|
| Cay34550-0.05 |
CAS: 71030-37-0 Bioactive lipid studies (±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)12-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34560 and Cay34570). It aggregates ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
128 €
|
| Cay34550-0.1 |
CAS: 71030-37-0 Bioactive lipid studies (±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)12-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34560 and Cay34570). It aggregates ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
242 €
|
| Cay34550-0.25 |
CAS: 71030-37-0 Bioactive lipid studies (±)12-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)12-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34560 and Cay34570). It aggregates ... mehr MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
538 €
|
| Cay34560-100 |
CAS: 82337-46-0 Bioactive lipid assays In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay34560-250 |
CAS: 82337-46-0 Bioactive lipid assays In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
974 €
|
| Cay34560-50 |
CAS: 82337-46-0 Bioactive lipid assays In mammals, 12(R)-HETE can be produced by 12(R)-LOs and also by CYP450 oxidation. The activity of 12(R)-HETE in mammals is predominantly proinflammatory. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay34565-0.025 |
CAS: 135271-51-1 Bioactive lipid studies Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta-oxidation from C-1. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE ... mehr MW: 266 D Formula: C16H26O3 Purity: >98% |
Cayman |
25 µg |
118 €
|
| Cay34565-0.05 |
CAS: 135271-51-1 Bioactive lipid studies Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta-oxidation from C-1. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE ... mehr MW: 266 D Formula: C16H26O3 Purity: >98% |
Cayman |
50 µg |
225 €
|
| Cay34565-0.1 |
CAS: 135271-51-1 Bioactive lipid studies Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta-oxidation from C-1. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE ... mehr MW: 266 D Formula: C16H26O3 Purity: >98% |
Cayman |
100 µg |
426 €
|
| Cay34570 |
CAS: 84807-90-9 Standard 12(S)-HETE-d8 contains eight deuterium atoms at the 5, 6, 8, 9, 11, 12, 14 and 15 positions. It is intended for use as an internal standard for the quantification of 12(S)-HETE by GC- or LC-mass spectrometry (MS). MW: 328 D Formula: C20H24D8O3 Purity: >99% deuterated product |
Cayman |
50 µg |
267 €
|
| Cay34570-100 |
CAS: 54397-83-0 Bioactive lipid assays 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
441 €
|
| Cay34570-25 |
CAS: 54397-83-0 Bioactive lipid assays 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
139 €
|
| Cay34570-250 |
CAS: 54397-83-0 Bioactive lipid assays 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
974 €
|
| Cay34570-50 |
CAS: 54397-83-0 Bioactive lipid assays 12(S)-HETE is the predominant lipoxygenase product of mammalian platelets. It enhances tumor cell adhesion to endothelial cells, fibronectin, and the subendothelial matrix at 0.1 µM. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
232 €
|
| Cay34700-0.025 |
CAS: 73836-87-0 Bioactive lipid studies (±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34720 and Cay34710). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
56 €
|
| Cay34700-0.05 |
CAS: 73836-87-0 Bioactive lipid studies (±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34720 and Cay34710). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
106 €
|
| Cay34700-0.1 |
CAS: 73836-87-0 Bioactive lipid studies (±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34720 and Cay34710). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
199 €
|
| Cay34700-0.25 |
CAS: 73836-87-0 Bioactive lipid studies (±)15-HETE is one of the six monohydroxy fatty acids produced by the non-enzymatic oxidation of arachidonic acid. The biological activity of (±)15-HETE is similar to that of its constituent enantiomers (Catalog Nos. Cay34720 and Cay34710). MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
445 €
|
| Cay34710-0.025 |
CAS: 83603-31-0 Bioactive lipid studies 15(R)-HETE is produced when aspirin-inhibited COX-2 is incubated with arachidonic acid. The clinical significance of 15(R)-HETE and its potential downstream metabolites is the subject of current investigations. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
95 €
|
| Cay34710-0.05 |
CAS: 83603-31-0 Bioactive lipid studies 15(R)-HETE is produced when aspirin-inhibited COX-2 is incubated with arachidonic acid. The clinical significance of 15(R)-HETE and its potential downstream metabolites is the subject of current investigations. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
172 €
|
| Cay34710-0.1 |
CAS: 83603-31-0 Bioactive lipid studies 15(R)-HETE is produced when aspirin-inhibited COX-2 is incubated with arachidonic acid. The clinical significance of 15(R)-HETE and its potential downstream metabolites is the subject of current investigations. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
299 €
|
| Cay34710-0.25 |
CAS: 83603-31-0 Bioactive lipid studies 15(R)-HETE is produced when aspirin-inhibited COX-2 is incubated with arachidonic acid. The clinical significance of 15(R)-HETE and its potential downstream metabolites is the subject of current investigations. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
250 µg |
632 €
|
| Cay34720-100 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
145 €
|
| Cay34720-25 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
25 µg |
45 €
|
| Cay34720-50 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
81 €
|
| Cay34720-500 |
CAS: 54845-95-3 Bioactive lipid assays 15(S)-HETE is a major arachidonic acid metabolite from the 15-lipoxygenase pathway. In mammals, 15(S)-HETE is synthesized in the respiratory epithelium, leukocytes, and reticulocytes. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
633 €
|
| Cay34722-0.025 |
Affinity binding 15(S)-HETE is a major arachidonic acid metabolite produced by the 15-lipoxygenase pathway. It has been characterized as a potent inhibitor of 5-lipoxygenase. The mechanism by which 15(S)-HETE acts as a leukotriene inhibitor is not clear. In studies with P ... mehr MW: 560 D Formula: C30H48N4O4S Purity: >98% |
Cayman |
25 µg |
118 €
|
| Cay34722-0.05 |
Affinity binding 15(S)-HETE is a major arachidonic acid metabolite produced by the 15-lipoxygenase pathway. It has been characterized as a potent inhibitor of 5-lipoxygenase. The mechanism by which 15(S)-HETE acts as a leukotriene inhibitor is not clear. In studies with P ... mehr MW: 560 D Formula: C30H48N4O4S Purity: >98% |
Cayman |
50 µg |
225 €
|
| Cay34722-0.1 |
Affinity binding 15(S)-HETE is a major arachidonic acid metabolite produced by the 15-lipoxygenase pathway. It has been characterized as a potent inhibitor of 5-lipoxygenase. The mechanism by which 15(S)-HETE acts as a leukotriene inhibitor is not clear. In studies with P ... mehr MW: 560 D Formula: C30H48N4O4S Purity: >98% |
Cayman |
100 µg |
426 €
|
| Cay35200-0.025 |
CAS: 82948-88-7 LTD4 receptor agonist 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
99 €
|
| Cay35200-0.05 |
CAS: 82948-88-7 LTD4 receptor agonist 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
189 €
|
| Cay35200-0.1 |
CAS: 82948-88-7 LTD4 receptor agonist 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
360 €
|
| Cay35200-0.25 |
CAS: 82948-88-7 LTD4 receptor agonist 5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
798 €
|
| Cay35210-0.025 |
CAS: 82948-87-6 Bioactive lipid studies 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
166 €
|
| Cay35210-0.05 |
CAS: 82948-87-6 Bioactive lipid studies 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
316 €
|
| Cay35210-0.1 |
CAS: 82948-87-6 Bioactive lipid studies 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
597 €
|
| Cay35210-0.25 |
CAS: 82948-87-6 Bioactive lipid studies 5(S),6(S)-DiHETE is one of the four diastereomeric 5,6-dihydroxy acids produced from the non-enzymatic hydrolysis of LTA4. 5(S),6(S)-DiHETE does not have significant leukotriene-like activity. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
1327 €
|
| Cay35280-100 |
CAS: 82200-87-1 Bioactive lipid assays Synthesized by 15-LO from 5(S)-HETE.{306} It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
288 €
|
| Cay35280-25 |
CAS: 82200-87-1 Bioactive lipid assays Synthesized by 15-LO from 5(S)-HETE.{306} It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
80 €
|
| Cay35280-250 |
CAS: 82200-87-1 Bioactive lipid assays Synthesized by 15-LO from 5(S)-HETE.{306} It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
640 €
|
| Cay35280-50 |
CAS: 82200-87-1 Bioactive lipid assays Synthesized by 15-LO from 5(S)-HETE.{306} It potentiates the degranulation of human PMNL in response to PAF, but not fMLP, calcium ionophore A23187, or LTB4. 5(S),15(S)-DiHETE is chemotactic for eosinophils with an ED50 value of 0.3 µM. MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
152 €
|
| Cay35370-0.025 |
CAS: 80234-65-7 Bioactive lipid studies 8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 µM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),1 ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
25 µg |
80 €
|
| Cay35370-0.05 |
CAS: 80234-65-7 Bioactive lipid studies 8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 µM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),1 ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
50 µg |
152 €
|
| Cay35370-0.1 |
CAS: 80234-65-7 Bioactive lipid studies 8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 µM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),1 ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
100 µg |
288 €
|
| Cay35370-0.25 |
CAS: 80234-65-7 Bioactive lipid studies 8(S),15(S)-DiHETE is formed when 15(S)-HETE is subjected to further oxidation by 15-LO. It causes eosinophil chemotaxis with an ED50 value of 1.5 µM but is not chemotactic for neutrophils. 8(S),15(S)-DiHETE antagonizes the hyperalgesic activity of 8(R),1 ... mehr MW: 336 D Formula: C20H32O4 Purity: >98% |
Cayman |
250 µg |
640 €
|
| Cay390030-100 |
Standard 20-HETE-d6 contains six deuterium atoms at the 16, 16', 17, 17', 18 and 18' positions. It is intended for use as an internal standard for the quantification of 20-HETE by GC- or LC-mass spectrometry. MW: 326 D Formula: C20H26D6O3 Purity: >99% deuterated product |
Cayman |
100 µg |
606 €
|
| Cay390030-25 |
Standard 20-HETE-d6 contains six deuterium atoms at the 16, 16', 17, 17', 18 and 18' positions. It is intended for use as an internal standard for the quantification of 20-HETE by GC- or LC-mass spectrometry. MW: 326 D Formula: C20H26D6O3 Purity: >99% deuterated product |
Cayman |
25 µg |
168 €
|
| Cay390030-50 |
Standard 20-HETE-d6 contains six deuterium atoms at the 16, 16', 17, 17', 18 and 18' positions. It is intended for use as an internal standard for the quantification of 20-HETE by GC- or LC-mass spectrometry. MW: 326 D Formula: C20H26D6O3 Purity: >99% deuterated product |
Cayman |
50 µg |
320 €
|
| Cay434720-100 |
15(S)-HETE AChE tracer Tracer |
Cayman |
100 assays |
175 €
|
| Cay434720-500 |
15(S)-HETE AChE tracer Tracer |
Cayman |
500 assays |
645 €
|
| Cay434724-1 |
15(S)-HETE EIA standard EIA standard |
Cayman |
1 each |
26 €
|
| Cay90030-100 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
100 µg |
499 €
|
| Cay90030-50 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
50 µg |
264 €
|
| Cay90030-500 |
CAS: 79551-86-3 Bioactive lipid assays 20-HETE is a cytochrome P450 (CYP450) metabolite postulated to play an autacoid role in the renal and cerebral vasculature. In rat cerebral microvessels, 20-HETE is a vasoconstrictor that mediates pressure-induced autoregulatory vasoconstriction. MW: 320 D Formula: C20H32O3 Purity: >98% |
Cayman |
500 µg |
2227 €
|
Warenkorb
